Aug. 25-29
Ft. Lauderdale, Fla.
2010 National Gay Men's Health Summit
Sep. 12-15
Orlando, Fla.
2010 United States Conference on AIDS
Sep. 12-15
Boston, Mass.
50th Interscience Conference on Antimicrobial Agents and Chemotherapy
Aug. 25-29
Ft. Lauderdale, Fla.
2010 National Gay Men's Health Summit
Sep. 12-15
Orlando, Fla.
2010 United States Conference on AIDS
Sep. 12-15
Boston, Mass.
50th Interscience Conference on Antimicrobial Agents and Chemotherapy
Health Care Need in Haiti: Volunteer doctors and nurses needed to staff three clinics in Haiti. If you would like to volunteer, please contact Dr. Vaty Poitevien. For more information on the project, click here.
Save Lives in Haiti: Please send medicine to AID FOR AIDS International. Click here for more information.
The U.S. HIV Health Care Crisis: How Did We Get Here?
HIV Testing Is Now a Routine Part of Health Care in New York
ADAP Wait Lists Near 3,500, but Some Relief Is on the Way
Two FDA-Approved Cancer Drugs May Be Effective Against HIV, Lab Tests Find
Clinical Management of the HIV-Infected Woman
A Podcast Discussion With Kimberly Smith, M.D., M.P.H., and Valerie Stone, M.D., M.P.H.
New Paradigms of First-Line HIV Therapy: Determining When (and With What) to Start
A Podcast Discussion With Eric Daar, M.D., and Trevor Hawkins, M.D.
HIV Frontlines
An Interview With Debbie Hagins, M.D., Clinical Director of a Ryan White Clinic in Georgia
Bone Disease and HIV/AIDS: More Common Than You Think
An Interview With Todd Brown, M.D., Ph.D., and Ben Young, M.D., Ph.D.
Can a Trofile Assay Be Used to Predict HIV Disease Progression?
An Interview With Matthew Goetz, M.D.
Innovative Widget Provides N.Y. Emergency Rooms With PEP Info
An Interview With Antonio Urbina, M.D.
Virologic Suppression Is Less Likely Among Antiretroviral-Experienced Black Women. But Why?
A Discussion With Kimberly Smith, M.D., M.P.H.
Which IAS 2009 Studies Are Most Likely to Impact Clinical Care?
A Discussion With Joel Gallant, M.D., M.P.H.
During First 45 Days Post HAART Initiation Patients Hospitalized Most Often for Non-AIDS-Defining Infections
An Interview With Stephen Berry, M.D.